Pimagedine hydrochlorideProduct ingredient for Pimagedine
- Name
- Pimagedine hydrochloride
- Drug Entry
- Pimagedine
Pimagedine has been developed by Synvista Therapeutics, Inc for the treatment of diabetic kidney disease. It is an advanced glycation end product inhibitor which manages diabetic nephropathy, either alone or in combination with other therapies. It is beneficial in treating patients with diabetic nephropathy.
- Accession Number
- DBSALT002490
- Structure
Structure for Pimagedine hydrochloride (DBSALT002490)
- Synonyms
- Aminoguanidine HCl / Aminoguanidine hydrochloride / Aminoguanidine monohydrochloride / Pimagedine HCl / Pimagedine hydrochloride
- External IDs
- GER-11